University of Leeds Featured PhD Programmes
FindA University Ltd Featured PhD Programmes
Norwich Research Park Featured PhD Programmes
Engineering and Physical Sciences Research Council Featured PhD Programmes
The Hong Kong Polytechnic University Featured PhD Programmes
"cell" AND "therapy"×
10 miles

cell therapy PhD Projects, Programs & Scholarships

We have 106 cell therapy PhD Projects, Programs & Scholarships

  • "cell" AND "therapy" ×
  • clear all
Order by 
Showing 1 to 10 of 106
  Characterisation and preclinical evaluation of a fibroblast-activating protein (FAP) targeted TRUCK CAR T-cell therapy for malignant pleural mesothelioma (MPM)
  Dr A Klampatsa, Prof A Melcher, Prof C Isacke
Application Deadline: 17 November 2019

Funding Type

PhD Type

The Institute of Cancer Research, London, is one of the world’s most influential cancer research institutes. We are committed to attracting and developing the best minds in the world to join us in our mission—to make the discoveries that defeat cancer.
  Gene and Cell Therapy For Muscular Dystrophy, Muscular Atrophy, Diabetes and Metabolic conditions
  Dr K Foster
Applications accepted all year round

Funding Type

PhD Type

Skeletal muscle development is a complex process and a number of regulatory factors for the different steps involved in stem cell activation and proliferation through to multinucleated, post-mitotic cells have been identified.
  The phenotypic and functional identification of angiogenic T-cells for potential use to treat cardiovascular disease Project ID SAS0043
  Dr M Ross, Dr G Wright
Application Deadline: 31 May 2020

Funding Type

PhD Type

PROJECT DESCRIPTION. This project is based within the School of Applied Sciences at Edinburgh Napier University and is led by Dr.
  Assessing the ability of hypoxic pre-conditioning to enhance the immunomodulatory capacity of canine cardiac stem cell as a bridge to the treatment of dilated cardiomyopathy.
  Dr D Connolly
Applications accepted all year round

Funding Type

PhD Type

Dilated Cardiomyopathy (DCM) is a common and serious disease, which imposes a significant welfare burden in dogs. DCM is particularly well characterise in Dobermans where a 58.8% cumulative prevalence has been identified in European lines.
  Identifying the role of glycosaminoglycans and microglia in early pathology of mucopolysaccharide diseases
  Dr B BIgger, Dr R Holley, Prof S Flitsch
Applications accepted all year round

Funding Type

PhD Type

Mucopolysaccharidoses (MPS) are inherited metabolic disorders caused by the deficiency of specific lysosomal enzymes required for the catabolism of glycosaminoglycans (GAGs) where each MPS type lacks a specific enzyme resulting in the build-up of GAGs in all cells of the body.
  Exploiting tumour-promoting paracrine signals in solid cancers to turbocharge genetically redirected T cells
  Dr A Hurlstone, Prof R Edmondson
Applications accepted all year round

Funding Type

PhD Type

Adoptive cell therapy (ACT) using tumour infiltrating lymphocytes (TILs) or genetically redirected T cells are some of the most promising approaches to emerge recently for the treatment of metastatic disease.
  Creating “super” regulatory T cells to combat rejection, GVHD and autoimmunity through retroviral gene manipulation
  Dr N Jones, Dr S Lee
Applications accepted all year round

Funding Type

PhD Type

Research interests/description of main research theme. Foxp3+CD25+CD4+ regulatory T cells (Treg) have been shown to be essential for the induction of tolerance to foreign organ transplants in experimental models.
  (MRC DTP) Exploiting tumour-promoting paracrine signals in solid cancers to turbocharge genetically redirected T cells
  Dr A Hurlstone, Prof R Edmondson
Application Deadline: 15 November 2019

Funding Type

PhD Type

Adoptive cell therapy (ACT) using tumour infiltrating lymphocytes (TILs) or genetically redirected T cells are some of the most promising approaches to emerge recently for the treatment of metastatic disease.
  Enhancement of radiation induced cell death using ultrasound stimulated microbubbles
  Dr E Harris, Dr C Box, Prof K Harrington
Application Deadline: 17 November 2019

Funding Type

PhD Type

The Institute of Cancer Research, London, is one of the world’s most influential cancer research institutes. We are committed to attracting and developing the best minds in the world to join us in our mission—to make the discoveries that defeat cancer.
  Role of Desmoglein-3 in regulating the YAP-Hippo pathway in cancer
  Dr H Wan
Applications accepted all year round

Funding Type

PhD Type

Project Description. Applications are invited for a 4-year PhD within a multidisciplinary and integrative research team in The Centre of Immunobiology and Regenerative Medicine, Institute of Dentistry.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.